<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) is a <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e> that causes venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> in virtually any organ and is responsible for fetal losses and <z:e sem="disease" ids="C0151864" disease_type="Disease or Syndrome" abbrv="">pregnancy disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Previously, APS was thought to be present mainly in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The spectrum of clinical manifestations is wide, because the thrombotic process may involve arterial and venous vessels of any size in any organ </plain></SENT>
<SENT sid="3" pm="."><plain>At present, there is no evidence to support or refute specific treatment strategies for primary prophylaxis of <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>